Calxyt, inc. announces pricing of $10.9 million sec-registered offering of common stock and warrants

Roseville, minn., feb. 17, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt) ("calyxt" or the "company"), a plant-based synthetic biology company, today announced the placement to an institutional investor in an underwritten offering of 3,880,000 shares of its common stock, pre-funded warrants to purchase up to 3,880,000 shares of its common stock, and common warrants to purchase up to 7,760,000 shares of its common stock (the "offering").
CLXT Ratings Summary
CLXT Quant Ranking